Search Results for "insulin lispro"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for insulin lispro. Results 1 to 2 of 2 total matches.
See also: Humalog
Lyumjev - A New Insulin Lispro for Diabetes
The Medical Letter on Drugs and Therapeutics • Oct 19, 2020 (Issue 1609)
Lyumjev - A New Insulin Lispro for Diabetes ...
The FDA has approved insulin lispro-aabc (Lyumjev –
Lilly), a faster-acting formulation of insulin lispro
(Humalog), for treatment of type 1 and type 2 diabetes
in adults. Fiasp, a faster-acting formulation of insulin
aspart (Novolog), was approved in 2017.
In Brief: Semglee - A New Insulin Glargine for Diabetes
The Medical Letter on Drugs and Therapeutics • Jan 25, 2021 (Issue 1616)
to receive
once-daily treatment with Semglee or Lantus in
addition to mealtime insulin lispro. In both ...
The FDA has approved Semglee (Mylan), an insulin
glargine product similar to Lantus, for treatment of
type 1 diabetes in children and adults and type 2
diabetes in adults. Semglee is the second "follow-on"
insulin glargine product to become available in
the US; Basaglar, which is also similar to Lantus, was
the first. Lantus is a recombinant analog of human
insulin that forms microprecipitates in subcutaneous
tissue, prolonging its duration of action to a mean of
about 24 hours with no pronounced peak effect.